Literature DB >> 19032100

Molecular-based synthetic approach to new group IV materials for high-efficiency, low-cost solar cells and Si-based optoelectronics.

Yan-Yan Fang1, Junqi Xie, John Tolle, Radek Roucka, Vijay R D'Costa, Andrew V G Chizmeshya, Jose Menendez, John Kouvetakis.   

Abstract

Ge(1-x-y)Si(x)Sn(y) alloys have emerged as a new class of highly versatile IR semiconductors offering the potential for independent variation of band structure and lattice dimension, making them the first practical group IV ternary system fully compatible with Si CMOS processing. In this paper we develop and apply new synthetic protocols based on designer molecular hydrides of Si, Ge, and Sn to demonstrate this concept from a synthesis perspective. Variation of the Si/Sn ratio in the ternary leads to an entirely new family of semiconductors exhibiting tunable direct band gaps (E(o)) ranging from 0.8 to 1.2 eV at a fixed lattice constant identical to that of Ge, as required for the design of high-efficiency multijunction solar cells based on group IV/III-V hybrids. As a proof-of-concept demonstration, we fabricated lattice-matched Si(100)/Ge/SiGeSn/InGaAs architectures on low-cost Si(100) substrates for the first time. These exhibit the required optical, structural, and thermal properties, thus representing a viable starting point en route to a complete four-junction photovoltaic device. In the context of Si-Ge-Sn optoelectronic applications, we show that Ge(1-x-y)Si(x)Sn(y) alloys serve as higher-gap barrier layers for the formation of light emitting structures based on Ge(1-y)Sn(y) quantum wells grown on Si.

Entities:  

Year:  2008        PMID: 19032100     DOI: 10.1021/ja806636c

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  1 in total

Review 1.  Growth and applications of GeSn-related group-IV semiconductor materials.

Authors:  Shigeaki Zaima; Osamu Nakatsuka; Noriyuki Taoka; Masashi Kurosawa; Wakana Takeuchi; Mitsuo Sakashita
Journal:  Sci Technol Adv Mater       Date:  2015-07-28       Impact factor: 8.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.